AMGN Stock Price Today $178.24
Year To Date
The Year To Date (YTD) return is +0.70%.
52 Week Low
The 52 Week Low stock price is 153.56 set on Tue, May 30, 2017 which is 361 days ago.
The current price per share is 16.07% above the 52 week low.
52 Week High
The 52 Week High stock price is $201.23 set on Mon, Jan 29, 2018 which is 117 days ago.
The current price per share is -11.42% below the 52 week high.
All Time High
The All Time High stock price is $201.23 set on Mon, Jan 29, 2018 which is 117 days ago.
The current price per share is -11.42% below the all time high.
Amgen Stock Charts
5 Year Stock Chart
The Amgen 5 year stock chart shows the historical prices over the previous 60 months.
1 Year Stock Chart
The Amgen 1 year stock chart shows the historical prices over the previous 12 months.
50 Day Moving Average
The 50 Day Moving Average is at $173.51 which is 2.73% below the stock price of $178.24.
200 Day Moving Average
The 200 Day Moving Average is at 178.44 which is -0.11% below the stock price of $178.24.
AMGN Company Profile
Amgen Inc is a Health Care stock that trades on the NASDAQ and has a market capitalization of $117.76 Billion.
AMGN is also one of the largest companies by market capitalization today.
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .
Earnings Per Share
The EPS is $2.69.
Price To Earnings Ratio
The P/E Ratio is 66.26
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Amgen Inc was Thu, Feb 1, 2018.
Since this earnings release 114 days ago, the stock price is down by -4.20%.
The most recent Earnings Release Date was on Tue, Apr 24, 2018, which was 32 days ago.
Since this earnings date, the stock price is up by +2.05%.
The Annual Dividend Yield is 2.96%.
Check out the Dividend Calculator to forecast your potential profis with Amgen.
Since the Ex-Date on Wed, May 16, 2018, 10 days ago, the stock price is up by 6.45%.
(The next ex-dividend date will be around Tue, Aug 14, 2018.)